Status | Study |
Completed |
Study Name: Open-label Vitamin D Trial for Patients With Cystic Fibrosis and Allergic Bronchopulmonary Aspergillosis Condition: Cystic Fibrosis Allergic Bronchopulmonary Aspergillosis Date: 2010-10-14 Interventions: Dietary Supplement: cholecalciferol (Vitamin D3) 4,000 IU of cholecalciferol (Vitamin D3) orally every d |
Completed |
Study Name: Evaluation of Bronchial Inflammation in Allergic Bronchopulmonary Aspergillosis (ABPA) Condition: Cystic Fibrosis, Date: 2009-05-20 |
Terminated |
Study Name: An Exploratory Study to Assess Multiple Doses of Omalizumab in Patients With Cystic Fibrosis Complicated by Acute Bronchopulmonary Aspergillosis (ABPA) Condition: Cystic Fibrosis Allergic Bronchopulmonary Aspergillosis Date: 2008-11-07 Interventions: Drug: Omalizumab Omalizumab su |
Completed |
Study Name: Mechanisms of Immune Tolerance and Inflammation in Patients With Cystic Fibrosis With ABPA Condition: Cystic Fibrosis Allergic Bronchopulmonary Aspergillosis Date: 2008-01-01 |
Completed |
Study Name: Trial on the Efficacy and Safety of Two Different Glucocorticoid Dose Regimens in Allergic Bronchopulmonary Aspergillosis Condition: Date: 2024-04-29 |